Change in diabetic retinopathy through 2 years secondary analysis of a randomized clinical trial comparing aflibercept, bevacizumab, and ranibizumab

Susan B. Bressler, Danni Liu, Adam R. Glassman, Barbara A. Blodi, Alessandro A. Castellarin, Lee M. Jampol, Paul L. Kaufman, Michele Melia, Harinderjit Singh, John A. Wells

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Change in diabetic retinopathy through 2 years secondary analysis of a randomized clinical trial comparing aflibercept, bevacizumab, and ranibizumab'. Together they form a unique fingerprint.

Medicine & Life Sciences